Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Open-Label Trial Investigating Behavior Related to Ella® Use in a Simulated OTC Environment (LIBRella)

NCT03208985 is registered in ClinicalTrials.gov with HRA Pharma as lead sponsor.

NCT NCT03208985
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03208985 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Open-Label Trial Investigating Behavior Related to Ella® Use in a Simulated OTC Environment (LIBRella)
Lead sponsor
HRA Pharma
Phase
Phase 3
Overall status
Completed
Start date
May 23, 2017
Completion date
June 14, 2018
Enrollment
1,270 (actual)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

emergency contraception